| Record 6938 View: Standard | Glossary HistCite Guide |
|
Author(s): Doble A
Title: The role of excitotoxicity in neurodegenerative disease: Implications for therapy
Source: PHARMACOLOGY & THERAPEUTICS 81 (3): 163-221
Date: 1999 MAR
Document Type: Journal : Review
DOI:
Language: English
Comment:
Address: Rhone Poulenc Rorer SA, Dept Neurosci, F-92165 Antony, France.
Reprint: Doble, A, Rhone Poulenc Rorer SA, Dept Neurosci, 20 Ave Raymond
Aron,TRI 109, F-92165 Antony, France. E-mail:
Author Keywords: glutamic acid; excitotoxicity; calcium; stroke; amyotrophic lateral
sclerosis; NMDA
KeyWords Plus: METHYL-D-ASPARTATE; AMYOTROPHIC-LATERAL-SCLEROSIS; EXCITATORY AMINO-
ACIDS; CENTRAL-NERVOUS-SYSTEM; NMDA-RECEPTOR ANTAGONIST; MIDDLE
CEREBRAL-ARTERY; METABOTROPIC GLUTAMATE RECEPTORS; MOTOR-NEURON
DISEASE; GLYCINE MODULATORY SITE; AMPA-KAINATE RECEPTORS
Abstract: Glutamic acid is the principal excitatory neurotransmitter in the mammalian central nervous system. Glutamic acid binds to a variety of excitatory amino acid receptors, which are ligand gated ion channels. It is activation of these receptors that leads to depolarisation and neuronal excitation, In normal synaptic functioning, activation of excitatory amino acid receptors is transitory. However, if, for any reason, receptor activation becomes excessive or prolonged, the target neurones become damaged and eventually die. This process of neuronal death is called excitotoxicity and appears to involve sustained elevations of intracellular calcium levels. Impairment of neuronal energy metabolism may sensitise neurones to excitotoxic cell death. The principle of excitotoxicity has been well established experimentally, both in in vitro systems and in vivo, following administration of excitatory amino acids into the nervous system. A role for excitotoxicity in the aetiology or progression of several human neurodegenerative diseases has been proposed, which has stimulated much research recently. This has led to the hope that compounds that interfere with glutamatergic neurotransmission may be of clinical benefit in treating such diseases. However, except in the case of a few very rare conditions, direct evidence for a pathogenic role for excitotoxicity in neurological disease is missing. Much attention has been directed at obtaining evidence for a role for excitotoxicity in the neurological sequelae of stroke, and there now seems to be little doubt that such a process is indeed a determining factor in the extent of the lesions observed. Several clinical trials have evaluated the potential of antiglutamate drugs to improve outcome following acute ischaemic stroke, but to date, the results of these have been disappointing. In amyotrophic lateral sclerosis, neurolathyrism, and human immunodeficiency virus dementia complex, several lines of circumstantial evidence suggest that excitotoxicity may contribute to the pathogenic process. An antiglutamate drug, riluzole, recently has been shown to provide some therapeutic benefit in the treatment of amyotrophic lateral sclerosis. Parkinson's disease and Huntington's disease are examples of neurodegenerative diseases where mitochondrial dysfunction may sensitise specific populations of neurones to excitotoxicity from synaptic glutamic acid. The first clinical trials aimed at providing neuroprotection with antiglutamate drugs are currently in progress for these two diseases. (C) 1999 Elsevier Science Inc. All rights reserved.
Cited References: AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345 AIZENMAN E, 1989, NEURON, V2, P1257 AKAIKE N, 1987, NEUROSCI LETT, V79, P326 ALBERS GW, 1995, STROKE, V26, P254 ANDREW SE, 1993, NAT GENET, V4, P398 ANDREWS PI, 1996, CURR OPIN NEUROBIOL, V6, P673 ANDREWS PI, 1996, NEUROLOGY, V46, P242 ANGULO MC, 1997, J NEUROSCI, V17, P6685 ANIS NA, 1983, BRIT J PHARMACOL, V79, P565 APPELBAUM JS, 1991, NEUROLOGY S1, V41, P393 ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267 ARAKI T, 1990, RES EXP MED, V190, P19 ARONOWSKI J, 1996, NEUROPHARMACOLOGY, V35, P689 ARRIZA JL, 1994, J NEUROSCI, V14, P5559 ASHALL F, 1994, TRENDS BIOCHEM SCI, V19, P42 ASHE JH, 1989, BRAIN RES, V480, P234 ASHTON D, 1997, BRAIN RES, V745, P210 ASMARK H, 1993, J NEUROL NEUROSUR PS, V56, P197 ATLANTE A, 1997, J NEUROCHEM, V68, P2038 ATWOOD WJ, 1993, CLIN MICROBIOL REV, V6, P339 BAGETTA G, 1994, NEUROSCI LETT, V176, P97 BAKSHI R, 1992, BRAIN RES, V580, P255 BARNARD EA, 1996, TRENDS PHARMACOL SCI, V17, P305 BARON BM, 1992, J PHARMACOL EXP THER, V262, P947 BEAL MF, 1986, NATURE, V321, P168 BEAL MF, 1990, J NEUROCHEM, V55, P1327 BEAL MF, 1991, J NEUROCHEM, V57, P1068 BEAL MF, 1991, J NEUROSCI, V11, P1649 BEAL MF, 1992, FASEB J, V6, P3338 BEAL MF, 1993, J NEUROSCI, V13, P4181 BEAL MF, 1993, TRENDS NEUROSCI, V16, P125 BECKMAN JS, 1993, NATURE, V364, P584 BELAYEV L, 1995, STROKE, V26, P2313 BENARI Y, 1992, TRENDS NEUROSCI, V15, P333 BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603 BENSIMON G, 1994, NEW ENGL J MED, V330, P585 BENVENISTE H, 1984, J NEUROCHEM, V43, P1369 BENVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131 BERMAN FW, 1997, J NEUROCHEM, V69, P693 BETTLER B, 1990, NEURON, V5, P583 BETTLER B, 1992, NEURON, V8, P257 BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123 BISCOE TJ, 1975, NATURE, V255, P166 BIZIERE K, 1979, J NEUROSCI RES, V4, P383 BLAKELY RD, 1987, BRAIN RES, V402, P373 BLAKELY RD, 1988, INT REV NEUROBIOL, V30, P39 BLANCHET PJ, 1997, NEUROSCI BIOBEHAV R, V21, P447 BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528 BLEAKMAN D, 1996, NEUROPHARMACOLOGY, V35, P1689 BLIN O, 1994, J NEUROL NEUROSUR PS, V57, P119 BLIN O, 1996, CLIN NEUROPHARMACOL, V19, P189 BOCHET P, 1994, NEURON, V12, P383 BOCKAERT J, 1993, FUND CLIN PHARM, V7, P473 BOIREAU A, 1994, NEUROREPORT, V5, P2157 BOIREAU A, 1994, NEUROREPORT, V5, P2657 BOLANOS JP, 1997, J NEUROCHEM, V68, P2227 BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162 BORDI F, 1997, EXP NEUROL, V145, P425 BOULTER J, 1990, SCIENCE, V249, P1033 BOWIE D, 1995, NEURON, V15, P435 BRACKLEY PTH, 1993, J PHARMACOL EXP THER, V266, P1573 BRADBURY AJ, 1986, NATURE, V319, P56 BRAUGHLER JM, 1992, J NEUROTRAUMA S1, V9, PS1 BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682 BREDT DS, 1992, NEURON, V8, P3 BRENMAN JE, 1997, CURR OPIN NEUROBIOL, V7, P374 BRENNEMAN DE, 1988, NATURE, V335, P639 BRIDGES RJ, 1989, J NEUROSCI, V9, P2073 BRISTOL LA, 1996, ANN NEUROL, V39, P676 BRODIE MJ, 1992, LANCET, V339, P1397 BRORSON JR, 1992, MOL PHARMACOL, V41, P603 BRORSON JR, 1994, J NEUROSCI, V14, P187 BROSNANWATTERS G, 1996, PHARMACOL BIOCHEM BE, V53, P701 BROUILLET E, 1993, J NEUROCHEM, V60, P356 BROUILLET E, 1993, NEUROREPORT, V4, P387 BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105 BROWN RH, 1995, CELL, V80, P687 BROWNE SE, 1994, BRAIN RES, V641, P10 BROWNE SE, 1997, ANN NEUROL, V41, P646 BRUIJN LI, 1997, NEURON, V18, P327 BRYSON HM, 1996, DRUGS, V52, P549 BUCHAN A, 1990, J NEUROSCI, V10, P311 BUCHAN A, 1991, J NEUROSCI, V11, P1049 BUCHAN AM, 1990, CERBROVAS BRAIN MET, V2, P1 BUCHAN AM, 1991, NEUROSCI LETT, V132, P255 BUCHAN AM, 1993, STROKE S1, V24, P148 BURKE JR, 1996, NAT MED, V2, P347 BURNASHEV N, 1992, NEURON, V8, P189 BURNASHEV N, 1992, SCIENCE, V256, P1566 BURNS RS, 1983, P NATL ACAD SCI USA, V80, P4546 BUTCHER SP, 1990, STROKE, V21, P1727 BZDEGA T, 1997, J NEUROCHEM, V69, P2270 CAMPOCHIARO P, 1978, P NATL ACAD SCI USA, V75, P2025 CAMU W, 1993, ACTA NEUROL SCAND, V88, P51 CARBONI S, 1990, NEUROSCI LETT, V117, P129 CARLING RW, 1997, J MED CHEM, V40, P754 CARRIEDO SG, 1996, J NEUROSCI, V16, P4069 CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222 CARTER CJ, 1989, EUR J PHARMACOL, V146, P611 CARTER CJ, 1990, J PHARMACOL EXP THER, V253, P475 CASSIDY M, 1993, NEUROPEPTIDES, V24, P271 CASTILLO PE, 1997, NATURE, V388, P182 CENDES F, 1995, ANN NEUROL, V37, P123 CHAN P, 1997, J PHARMACOL EXP THER, V280, P439 CHAN PH, 1980, J NEUROCHEM, V35, P1004 CHAPMAN AG, 1991, EPILEPSY RES, V9, P92 CHAZOT PL, 1992, J NEUROCHEM, V59, P1176 CHEN L, 1992, NATURE, V356, P521 CHERAMY A, 1992, NEUROSCI LETT, V147, P209 CHITTAJALLU R, 1996, NATURE, V379, P78 CHOI DW, 1985, NEUROSCI LETT, V58, P293 CHOI DW, 1987, J NEUROSCI, V7, P369 CHOI DW, 1988, J NEUROSCI, V8, P185 CHOI DW, 1988, NEURON, V1, P623 CHOI DW, 1988, TRENDS NEUROSCI, V11, P465 CHOI DW, 1996, CURR OPIN NEUROBIOL, V6, P667 CHRISTOPHERSON KS, 1997, J CLIN INVEST, V100, P2424 CIABARRA AM, 1995, J NEUROSCI, V15, P6498 CIABARRA AM, 1997, MOL BRAIN RES, V46, P85 CIK M, 1993, BIOCHEM J, V296, P877 CLARKE VRJ, 1997, NATURE, V389, P599 COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143 COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V10, P240 CONTRERAS PC, 1987, MOL NEUROBIOL, V1, P191 CORASANITI MT, 1995, NEURODEGENERATION, V4, P315 CORSI M, 1996, TRENDS PHARMACOL SCI, V17, P220 COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273 COURATIER P, 1993, LANCET, V341, P265 COYLE JT, 1978, J COMP NEUROL, V180, P301 COYLE JT, 1983, J NEUROCHEM, V41, P1 COYLE JT, 1997, NEUROBIOL DIS, V4, P231 CREGAN EF, 1997, J PHARMACOL EXP THER, V283, P1412 CROSSMAN AR, 1989, NEUROPHARMACOLOGY, V28, P1271 CUENOD M, 1993, BIOCHEM SOC T, V21, P72 CURTIS DR, 1959, NATURE, V183, P611 CURTIS DR, 1960, J NEUROCHEM, V6, P117 CURTIS DR, 1963, J PHYSIOL-LONDON, V66, P1 DALCANTO MC, 1994, AM J PATHOL, V145, P1271 DANBOLT NC, 1992, NEUROSCIENCE, V51, P259 DANYSZ W, 1997, NEUROSCI BIOBEHAV R, V21, P455 DAVIES J, 1979, J PHYSIOL-PARIS, V75, P641 DAVIES J, 1981, NEUROSCI LETT, V21, P77 DAVIES SW, 1988, NEUROSCIENCE, V26, P387 DAVIS SM, 1997, LANCET, V349, P32 DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368 DAWSON VL, 1993, P NATL ACAD SCI USA, V90, P3256 DAWSON VL, 1995, CLIN EXP PHARMACOL P, V22, P305 DERYCK M, 1996, J PHARMACOL EXP THER, V279, P748 DESSI F, 1993, EUR J PHARMACOL, V250, P325 DEXTER DT, 1989, J NEUROCHEM, V52, P381 DIDIER M, 1996, J NEUROSCI, V16, P2238 DIENER HC, 1996, STROKE, V27, P76 DIENER HC, 1997, J NEUROL SCI S, V150, PS199 DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286 DIFIGLIA M, 1995, NEURON, V14, P1075 DIMAURO S, 1993, NEUROLOGY, V43, P2170 DIOP AG, 1994, NEUROSCI LETT, V165, P187 DO KQ, 1986, J NEUROCHEM, V46, P779 DONEVAN SD, 1993, NEURON, V10, P51 DREYER EB, 1990, SCIENCE, V248, P364 DREYER EB, 1995, EUR J NEUROSCI, V7, P2502 DUNCAN MW, 1990, NEUROLOGY, V40, P767 DUVAL D, 1992, NEUROSCI LETT, V137, P193 DUYAO MP, 1995, SCIENCE, V269, P407 DYKENS JA, 1994, J NEUROCHEM, V63, P584 EGEBJERG J, 1991, NATURE, V351, P745 EISEN A, 1993, CAN J NEUROL SCI, V20, P297 ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245 ESTEVEZ AG, 1995, EUR J PHARMACOL, V280, P47 FADEN AI, 1988, ANN NEUROL, V23, P623 FADEN AI, 1988, J NEUROTRAUM, V5, P33 FADEN AI, 1989, SCIENCE, V244, P799 FAIRMAN WA, 1995, NATURE, V375, P599 FALLGREN AB, 1996, NEUROCHEM RES, V21, P19 FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983 FERKANY JW, 1982, NATURE, V298, P757 FERRANTE RJ, 1993, EXP NEUROL, V119, P46 FERRERMONTIEL AV, 1996, P NATL ACAD SCI USA, V93, P2741 FINIELS F, 1995, J NEUROCHEM, V65, P1027 FISCHER G, 1997, J PHARMACOL EXP THER, V283, P1285 FIX AS, 1993, EXP NEUROL, V123, P204 FLETCHER EJ, 1988, EUR J PHARMACOL, V151, P161 FORREST D, 1994, NEURON, V13, P325 FOSTER AC, 1984, BRAIN RES REV, V7, P103 FOSTER AC, 1988, J NEUROSCI, V8, P4745 FOSTER AC, 1989, J NEUROSCI, V9, P2191 FOSTER AC, 1992, MOL PHARMACOL, V41, P914 FOUTZ AS, 1994, NEUROREPORT, V5, P481 FUHRMAN S, 1994, J NEUROCHEM, V62, P275 GALLAGHER MJ, 1996, J BIOL CHEM, V271, P9603 GARRUTO RM, 1985, NEUROLOGY, V35, P193 GARRUTO RM, 1986, TRENDS NEUROSCI, V9, P368 GEE NS, 1996, J BIOL CHEM, V271, P5768 GEIGER JRP, 1995, NEURON, V15, P193 GEMBA T, 1994, NEUROSCIENCE, V63, P789 GERLACH M, 1994, J NEUROCHEM, V63, P793 GILBERTSON TA, 1991, SCIENCE, V251, P1613 GILL R, 1987, J NEUROSCI, V7, P3343 GILL R, 1990, EUR J PHARMACOL, V176, P143 GILL R, 1992, BRAIN RES, V580, P35 GILL R, 1994, CEREBROVAS BRAIN MET, V6, P225 GIULIAN D, 1990, SCIENCE, V250, P1593 GIULIAN D, 1993, P NATL ACAD SCI USA, V90, P2769 GLOWA JR, 1992, BRAIN RES, V570, P49 GORTELMEYER R, 1992, DRUG RES, V42, P904 GOTO K, 1990, BRAIN RES, V534, P299 GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211 GOULD DH, 1982, NEUROPATHOL APPL NEU, V8, P377 GREDAL O, 1996, EUR J NEUROL S5, V3, P132 GREENAMYRE JT, 1985, SCIENCE, V227, P1496 GREENE JG, 1995, J NEUROCHEM, V64, P430 GRIEVE A, 1991, NEUROCHEM INT, V19, P467 GRIMWOOD S, 1995, J NEUROCHEM, V64, P525 GROSSET DG, 1995, J CARDIOVASC PHARM, V25, P705 GROTTA J, 1994, STROKE, V25, P255 GROTTA J, 1997, STROKE, V28, P2338 GU M, 1996, ANN NEUROL, V39, P385 GUARDA AS, 1988, BRAIN RES, V427, P223 GURNEY ME, 1994, SCIENCE, V264, P1772 GURNEY ME, 1996, ANN NEUROL, V39, P147 GURNEY ME, 1998, NEUROLOGY, V50, P62 GUYOT MC, 1997, NEUROSCIENCE, V81, P141 HAMBERGER A, 1981, ADV BIOCHEM PSYCHOPH, V29, P509 HAMILTON BF, 1987, ACTA NEUROPATHOL, V72, P286 HARGREAVES RJ, 1993, BRIT J PHARMACOL, V110, P36 HARGREAVES RJ, 1993, NEUROCHEM RES, V18, P1263 HARRISON BL, 1990, J MED CHEM, V33, P3130 HASELDONCKX M, 1997, STROKE, V28, P428 HEBB DO, 1949, ORG BEHAV HEBERT T, 1994, MOL PHARMACOL, V45, P1055 HENNEBERRY RC, 1989, ANN NY ACAD SCI, V568, P225 HERB A, 1992, NEURON, V8, P775 HERLITZE S, 1993, NEURON, V10, P1131 HERNANDEZGUIJO JM, 1997, BRIT J PHARMACOL, V122, P275 HERON A, 1993, J NEUROCHEM, V61, P1973 HERRLING PL, 1994, NEUROPSYCHOPHARMACOL, V10, PS591 HERRON CE, 1986, NATURE, V322, P265 HEYES MP, 1989, ANN NEUROL, V26, P275 HEYES MP, 1991, ANN NEUROL, V29, P202 HEYES MP, 1992, BRAIN 5, V115, P1249 HEYES MP, 1996, BIOCHEM J 2, V320, P595 HILL JM, 1993, BRAIN RES, V603, P222 HIRONO I, 1972, FED PROC, V31, P1493 HIRSCH EC, 1994, NEURODEGENERATIVE DI, P155 HOLCOMB L, 1998, NAT MED, V4, P97 HOLLANDER D, 1992, ANN NEUROL, V32, P280 HOLLANDER D, 1994, ANN NEUROL, V36, P920 HOLLMANN M, 1989, NATURE, V342, P643 HOLLMANN M, 1991, SCIENCE, V252, P851 HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31 HONORE T, 1988, SCIENCE, V241, P701 HOOD WF, 1992, J PHARMACOL EXP THER, V262, P654 HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069 HSIAO KK, 1995, NEURON, V15, P1203 HUBERT JP, 1989, NEUROSCI LETT, V96, P345 HUBERT JP, 1994, BRIT J PHARMACOL, V113, P261 HUBERT JP, 1998, BRIT J PHARMACOL, V125, P1421 HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307 HUGON J, 1988, NEUROLOGY, V38, P435 HUGON J, 1989, NEUROSCI LETT, V104, P258 HUGON J, 1990, NEUROSCI LETT, V119, P45 HUME RI, 1991, SCIENCE, V253, P1028 HUNTER AJ, 1995, TRENDS PHARMACOL SCI, V16, P123 HYLTON C, 1995, J NEUROTRAUMA, V12, P124 IACOPINO A, 1992, MOL BRAIN RES, V13, P251 IADECOLA C, 1997, TRENDS NEUROSCI, V20, P132 IINO M, 1990, J PHYSIOL-LONDON, V424, P151 IINO M, 1996, J PHYSIOL-LONDON, V496, P431 IKONOMIDOU C, 1996, EXP NEUROL, V55, P211 INCE P, 1993, NEUROPATH APPL NEURO, V19, P291 ISA T, 1995, NEUROREPORT, V6, P2045 ISHII T, 1993, J BIOL CHEM, V268, P2836 ITO I, 1990, J PHYSIOL-LONDON, V424, P533 ITO I, 1997, J PHYSIOL-LONDON, V500, P401 IWASAKI Y, 1992, J NEUROL SCI, V107, P219 IWASAKI Y, 1995, NEUROL RES, V17, P393 JACKISCH R, 1994, EUR J PHARMACOL, V264, P207 JACKSON H, 1988, TRENDS NEUROSCI, V11, P278 JARROTT DM, 1980, STROKE, V11, P203 JENKINS BG, 1993, NEUROLOGY, V43, P2689 JIMONET P, 1994, BIOORGAN MED CHEM, V2, P793 JOHANSEN TH, 1993, EUR J PHARM-MOLEC PH, V246, P195 JOHANSEN TH, 1995, MOL PHARMACOL, V48, P946 JOHNSON JW, 1987, NATURE, V325, P529 JOHNSON TD, 1996, TRENDS PHARMACOL SCI, V17, P22 JONAS P, 1994, NEURON, V12, P1281 JONES M, 1972, FED PROC, V31, P1508 JONES MG, 1990, BRIT J PHARMACOL, V101, P968 JONES PG, 1991, NEUROSCI LETT, V111, P228 JONESHUMBLE SA, 1994, LIFE SCI, V54, P245 KAINANEN K, 1990, SCIENCE, V249, P556 KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297 KANAI Y, 1992, NATURE, V360, P467 KASHIWABUCHI N, 1995, CELL, V81, P245 KEILHOFF G, 1992, EUR J PHARMACOL, V219, P451 KELLER BU, 1993, P NATL ACAD SCI USA, V90, P602 KEMP JA, 1988, P NATL ACAD SCI USA, V85, P6547 KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20 KERR JFR, 1972, BRIT J CANCER, V26, P239 KESSLER M, 1989, BRAIN RES, V489, P377 KESSLER M, 1996, MOL PHARMACOL, V49, P123 KEW JNC, 1996, J PHYSIOL-LONDON, V497, P761 KIEBURTZ K, 1996, MOVEMENT DISORD, V11, P273 KIEDROWSKI L, 1994, MOL PHARMACOL, V45, P1050 KILPATRICK IC, 1986, NEUROSCI LETT, V72, P189 KIMURA H, 1985, J PHYSIOL-LONDON, V365, P103 KIROSCHETZ WWJ, 1996, TRENDS PHARMACOL SCI, V17, P227 KISBY GE, 1992, NEURODEGENERATION, V1, P73 KLANCNIK JM, 1992, NEUROSCIENCE, V49, P557 KLECKNER NW, 1988, SCIENCE, V241, P835 KLOCKGETHER T, 1991, ANN NEUROL, V30, P717 KOCH RA, 1994, J NEUROSCI 1, V14, P2585 KOCHHAR A, 1988, ARCH NEUROL-CHICAGO, V45, P148 KOEK W, 1990, J PHARMACOL EXP THER, V252, P349 KOEK W, 1990, J PHARMACOL EXP THER, V253, P1017 KOERNER JF, 1981, BRAIN RES, V216, P192 KOH DS, 1995, J PHYSIOL-LONDON, V485, P383 KOH DS, 1995, J PHYSIOL-LONDON, V486, P305 KOH JY, 1988, BRAIN RES, V446, P374 KOH JY, 1990, BRAIN RES, V533, P315 KOHLER C, 1988, NEUROSCIENCE, V27, P49 KORNHUBER J, 1995, NEUROSCI LETT, V195, P137 KRISTENSEN JD, 1992, PAIN, V51, P249 KUPSCH A, 1992, BRAIN RES, V592, P74 KURIHARA H, 1997, J NEUROSCI, V17, P9613 KURLAND LT, 1954, NEUROLOGY, V4, P355 KURLAND LT, 1954, NEUROLOGY, V4, P438 KURLAND LT, 1972, FED PROC, V31, P1540 KURLAND LT, 1988, TRENDS NEUROSCI, V11, P51 KUTSUWADA T, 1992, NATURE, V358, P36 KUTSUWADA T, 1996, NEURON, V16, P333 KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373 LACOMBLEZ L, 1996, LANCET, V347, P1425 LAMBOLEZ B, 1992, NEURON, V9, P247 LAMBOLEZ B, 1996, P NATL ACAD SCI USA, V93, P1797 LANDSEND AS, 1997, J NEUROSCI, V17, P834 LANGE KW, 1993, N-S ARCH PHARMACOL, V348, P586 LANGE KW, 1994, LIFE SCI, V55, P2067 LANGSTON JW, 1983, SCIENCE, V219, P979 LANIER WL, 1990, J CEREBR BLOOD F MET, V10, P252 LANNUZEL A, 1995, EUR J NEUROSCI, V7, P2285 LAVINE L, 1991, ADV NEUROL, V56, P271 LEACH MJ, 1986, EPILEPSIA, V27, P490 LEACH MJ, 1991, EPILEPSIA S2, V32, P4 LEACH MJ, 1993, STROKE, V24, P1063 LEES G, 1993, BRAIN RES, V612, P190 LEGENDRE P, 1991, MOL PHARMACOL, V40, P289 LEPEILLET E, 1992, BRAIN RES, V571, P115 LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688 LERMA J, 1997, TRENDS NEUROSCI, V20, P9 LESAGE AS, 1996, J PHARMACOL EXP THER, V279, P759 LESTER RAJ, 1989, MOL PHARMACOL, V35, P565 LEVI G, 1982, BRAIN RES, V239, P425 LI H, 1993, J CEREBR BLOOD F MET, V13, P933 LI Y, 1995, AM J PATHOL, V146, P1045 LIPTON SA, 1991, NEURON, V7, P111 LIPTON SA, 1992, EUR J NEUROSCI, V4, P1411 LIPTON SA, 1992, NEUROLOGY, V42, P1403 LIPTON SA, 1992, NEUROREPORT, V3, P913 LIPTON SA, 1992, TRENDS NEUROSCI, V15, P75 LIPTON SA, 1994, MOL NEUROBIOL, V8, P181 LIPTON SA, 1994, NEW ENGL J MED, V330, P613 LIU QR, 1993, J BIOL CHEM, V268, P22802 LO AC, 1995, ARCH HISTOL CYTOL, V58, P139 LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81 LOMBARDI G, 1983, ACTA PHARM TOXICO S1, V53, P24 LOMELI H, 1992, FEBS LETT, V307, P139 LOMELI H, 1993, FEBS LETT, V315, P318 LONGA EZ, 1989, STROKE, V20, P84 LU YM, 1995, NEUROREPORT, V6, P1089 LUCAS DR, 1957, AM MED ASSOC ARCH OP, V58, P193 LUDOLPH AC, 1991, CAN J NEUROL SCI, V18, P492 LUDOLPH AC, 1992, NEURODEGENERATION, V1, P155 LUKAS W, 1994, NEUROSCIENCE, V61, P307 LYNCH DR, 1994, MOL PHARMACOL, V45, P540 MACDONALD JF, 1987, J NEUROPHYSIOL, V58, P251 MACDONALD ME, 1993, CELL, V72, P971 MACDONALD ME, 1996, CURR OPIN NEUROBIOL, V6, P638 MACRAE IM, 1992, BRIT J CLIN PHARMACO, V34, P302 MAIESE K, 1997, J NEUROCHEM, V68, P710 MANGIARINI L, 1996, CELL, V87, P493 MANN VM, 1992, BRAIN 2, V115, P333 MARLER JR, 1995, NEW ENGL J MED, V333, P1581 MARTIN A, 1992, J NEUROPSYCH CLIN N, V4, P270 MARTIN D, 1993, EUR J PHARMACOL, V250, P473 MARTIN LJ, 1993, NEUROSCIENCE, V53, P327 MARTINOU JC, 1994, NEURON, V13, P1017 MARY V, 1995, NEUROSCI LETT, V201, P92 MASSIEU L, 1994, NEUROSCIENCE, V59, P931 MATTHEWS RT, 1997, J NEUROCHEM, V69, P285 MATTSON MP, 1992, J NEUROSCI, V12, P376 MAYAT E, 1995, J NEUROSCI 2, V15, P2533 MAYER ML, 1984, NATURE, V309, P261 MAYER ML, 1987, PROG NEUROBIOL, V28, P197 MCBEAN GJ, 1981, NATURE, V291, P593 MCCABE RT, 1993, J PHARMACOL EXP THER, V264, P1248 MCCORD JM, 1985, NEW ENGL J MED, V312, P159 MCCULLOCH J, 1992, BRIT J CLIN PHARMACO, V34, P106 MCDONALD JW, 1993, BRAIN RES, V624, P239 MCGEER EG, 1976, NATURE, V263, P517 MCGEER EG, 1978, BRAIN RES, V139, P381 MCILHINNEY RAJ, 1996, NEUROSCIENCE, V70, P989 MCINTOSH TK, 1989, J NEUROTRAUM, V6, P247 MCLENNAN H, 1979, BRAIN RES, V169, P83 MCMANIGLE JE, 1994, EUR J PHARMACOL, V252, P11 MEDEN P, 1993, J NEUROL SCI, V119, P209 MEGURO H, 1992, NATURE, V357, P70 MELDRUM B, 1990, CERBROVAS BRAIN MET, V2, P27 MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379 MELDRUM B, 1993, BRAIN RES REV, V18, P293 MELDRUM BS, 1992, BRAIN RES, V593, P1 MELDRUM BS, 1994, SEIZURE, V3, P41 MENNITI F, 1997, EUR J PHARMACOL, V331, P117 MENTIS GZ, 1993, NEUROSCIENCE, V54, P283 MERCER LD, 1993, J NEUROCHEM, V61, P120 MICHEL PP, 1992, BRAIN RES, V597, P233 MIGNANI S, 1995, DRUGS FUTURE, V20, P1133 MILLER RF, 1986, TRENDS NEUROSCI, V9, P211 MILLER RG, 1996, NEUROLOGY, V47, P1383 MILLS LR, 1990, NEURON, V2, P149 MODY I, 1988, NEUROSCI LETT, V93, P73 MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356 MOFFETT JR, 1989, BRAIN RES, V494, P255 MOFFETT JR, 1991, BRAIN RES, V538, P86 MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365 MONYER H, 1991, NEURON, V6, P779 MONYER H, 1992, SCIENCE, V256, P1217 MORIYOSHI K, 1991, NATURE, V354, P31 MOSINGER JL, 1991, EXP NEUROL, V113, P10 MUIR KW, 1994, BRIT J CLIN PHARMACO, V38, P33 MUIR KW, 1995, ANN NY ACAD SCI, V765, P328 MUIR KW, 1995, STROKE, V26, P503 MULLER T, 1992, SCIENCE, V256, P1563 MULLER WEG, 1992, EUR J PHARM-MOLEC PH, V226, P209 MYSEROS JS, 1995, ANN NY ACAD SCI, V765, P262 NADI NS, 1977, J NEUROCHEM, V28, P661 NAKANISHI N, 1990, NEURON, V5, P569 NAKAO N, 1996, NEUROSCIENCE, V73, P185 NASIR J, 1995, CELL, V81, P811 NAVIA BA, 1986, ANN NEUROL, V19, P517 NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462 NICOLETTI F, 1996, TRENDS NEUROSCI, V19, P267 NORMAN DJ, 1995, DEVELOPMENT, V121, P1183 NOVAK L, 1984, NATURE, V307, P462 NOVELLI A, 1988, BRAIN RES, V451, P205 NUNN PB, 1987, BRAIN RES, V410, P375 OHNO K, 1997, NEUROCHEM INT, V31, P715 OKADA M, 1996, EUR J PHARMACOL, V309, P299 OKIYAMA K, 1995, J NEUROCHEM, V64, P802 OLNEY JW, 1969, SCIENCE, V164, P719 OLNEY JW, 1969, SCIENCE, V166, P386 OLNEY JW, 1978, KAINIC ACID TOOL NEU, P95 OLNEY JW, 1987, EUR J PHARMACOL, V142, P319 OLNEY JW, 1989, SCIENCE, V244, P1360 OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335 ONODERA H, 1986, NEUROSCI LETT, V68, P169 ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281 ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895 OYE I, 1992, J PHARMACOL EXP THER, V260, P1209 PALFI S, 1997, EXP NEUROL, V146, P135 PALMER AJ, 1993, EUR J PHARM-MOLEC PH, V244, P193 PALMER KJ, 1993, DRUGS, V45, P1041 PANG Z, 1997, J NEUROSCI, V17, P3064 PANTER SS, 1990, ANN NEUROL, V27, P96 PARTIN KM, 1993, NEURON, V11, P1069 PASSANI LA, 1997, BRAIN RES, V772, P9 PATERNAIN AV, 1995, NEURON, V14, P185 PATERNAIN AV, 1996, EUR J NEUROSCI, V8, P2129 PATNEAU DK, 1992, J NEUROSCI, V12, P595 PAUWELS PJ, 1990, J PHARMACOL EXP THER, V255, P1117 PERL TM, 1990, NEW ENGL J MED, V322, P1775 PERRY TL, 1987, NEUROLOGY, V37, P1845 PERRY TL, 1990, ANN NEUROL, V28, P12 PETRALIA RS, 1997, J COMP NEUROL, V385, P456 PHILLIPS RJS, 1960, J GENET, V57, P35 PIN JP, 1995, CURR OPIN NEUROBIOL, V5, P342 PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1 PINES G, 1992, NATURE, V360, P464 PLAITAKIS A, 1987, ANN NEUROL, V22, P575 PLAITAKIS A, 1988, ANN NEUROL, V24, P446 PLAITAKIS A, 1992, NEUROLOGY S3, V42, P454 PLAITAKIS A, 1996, CNS DRUGS, V5, P437 POLLARD H, 1994, NEUROSCIENCE, V63, P7 PORTERACAILLIAU C, 1997, J COMP NEUROL, V378, P88 POWER C, 1995, CAN J NEUROL SCI, V22, P92 PRATT J, 1992, NEUROSCI LETT, V140, P225 PREHN JHM, 1995, EUR J PHARM-ENVIRON, V292, P179 PRICE CJ, 1996, MOL PHARMACOL, V50, P1665 PRIESTLEY T, 1989, BRIT J PHARMACOL, V97, P1315 PUCHALSKI RB, 1994, NEURON, V13, P131 PULLAN LM, 1987, J NEUROCHEM, V49, P1301 PULSINELLI WA, 1979, STROKE, V10, P499 RABEY JM, 1992, J NEURAL TRANSM-PARK, V4, P277 RAMNATH RR, 1992, NEUROSCIENCE, V51, P931 RAO SLN, 1964, BIOCHEMISTRY-US, V3, P432 RAO SLN, 1967, NATURE, V214, P610 RASMUSSEN T, 1958, NEUROLOGY, V8, P435 RATAUD J, 1994, NEUROSCI LETT, V172, P19 RECASENS M, 1982, BRAIN RES, V239, P153 REGAN RF, 1991, NEUROSCIENCE, V43, P585 REINER A, 1995, EXP NEUROL, V131, P239 REYNOLDS GP, 1988, J NEUROCHEM, V50, P1959 RIEPE MW, 1995, NEUROSCIENCE, V64, P91 RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P659 ROBINSON MB, 1987, J BIOL CHEM, V262, P14498 ROBINSON MB, 1992, PEDIATR RES, V32, P483 ROBINSON MJ, 1990, NEUROSCI LETT, V118, P269 ROCK DM, 1995, ANNU REV PHARMACOL, V35, P463 ROETTGER V, 1996, NEUROSCIENCE, V75, P677 ROGAWSKI MA, 1993, TRENDS PHARMACOL SCI, V14, P325 ROGERS SW, 1994, SCIENCE, V265, P648 ROSEN DR, 1993, NATURE, V362, P59 ROSS SM, 1987, BRAIN RES, V425, P120 ROSS SM, 1989, J NEUROCHEM, V53, P710 ROTHMAN S, 1984, J NEUROSCI, V4, P1884 ROTHMAN SM, 1983, SCIENCE, V220, P536 ROTHMAN SM, 1985, J NEUROSCI, V5, P1483 ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299 ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18 ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464 ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591 ROTHSTEIN JD, 1994, NEURON, V13, P713 ROTHSTEIN JD, 1995, ADV NEUROL, V68, P7 ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73 ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643 ROTHSTEIN JD, 1996, NEURON, V16, P675 SAITO K, 1992, NEUROSCIENCE, V51, P25 SAKIMURA K, 1995, NATURE, V373, P151 SALT TE, 1991, EXCITATORY AMINO ACI, P155 SANTIAGO M, 1992, BRAIN RES, V586, P203 SARMA PS, 1969, TOXIC CONSTITUENTS P, P265 SAVIO T, 1993, J NEUROSCI RES, V34, P265 SCHAPIRA AHV, 1989, LANCET, V1, P1269 SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823 SCHIFFER HH, 1997, NEURON, V19, P1141 SCHOEMAKER H, 1990, EUR J PHARMACOL, V176, P249 SCHULZ JB, 1995, J NEUROSCI, V15, P8419 SCHWARCZ R, 1983, SCIENCE, V219, P316 SCHWARCZ R, 1988, ANN NEUROL, V24, P580 SCHWARCZ R, 1988, P NATL ACAD SCI USA, V85, P4079 SEAWRIGHT AA, 1990, NEUROPATH APPL NEURO, V16, P153 SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297 SERVAL V, 1992, J PHARMACOL EXP THER, V260, P1093 SHARP FR, 1994, NEUROSCIENCE, V62, P1079 SHASHIDHARAN P, 1994, BRAIN RES, V662, P245 SHAW PJ, 1994, BRAIN RES, V655, P195 SHAW PJ, 1994, J NEUROL SCI S, V124, P6 SHAW PJ, 1995, NEURODEGENERATION, V4, P209 SHAW PJ, 1997, J NEUROL S2, V244, PS3 SHEARDOWN MJ, 1990, SCIENCE, V247, P571 SHEARDOWN MJ, 1993, EUR J PHARMACOL, V236, P347 SHENG M, 1994, NATURE, V368, P144 SHIMIZUSASAMATA M, 1996, J PHARMACOL EXP THER, V276, P84 SHUAIB A, 1995, BRAIN RES, V702, P199 SIDDIQUE T, 1996, NEUROLOGY S2, V47, PS27 SIMAN R, 1989, J NEUROSCI, V9, P1579 SIMON RP, 1984, SCIENCE, V226, P850 SINDOU P, 1994, J NEUROL SCI, V126, P133 SMITH DH, 1993, J NEUROSCI, V13, P5383 SMITH SE, 1990, EUR J PHARMACOL, V187, P131 SMITH SE, 1992, STROKE, V23, P861 SMITH SE, 1993, NEUROREPORT, V4, P1339 SOMMER B, 1990, SCIENCE, V249, P1580 SOMMER B, 1991, CELL, V67, P11 SOMMER B, 1992, EMBO J, V11, P1651 SONSALLA PK, 1991, J PHARMACOL EXP THER, V256, P506 SONSALLA PK, 1992, J NEUROCHEM, V58, P1979 SPATZ M, 1969, ANN NY ACAD SCI, V163, P848 SPENCER PS, 1983, NEUROBEH TOXICOL TER, V5, P625 SPENCER PS, 1986, LANCET, V2, P1066 SPENCER PS, 1987, SCIENCE, V237, P517 SPENCER PS, 1991, ADV NEUROL, V56, P287 SRIVASTAVA R, 1993, NEUROBIOL AGING, V14, P295 STARR MS, 1997, NEUROSCI BIOBEHAV R, V21, P437 STEINER TJ, 1994, MUSCLE NERVE S1, V17, PS166 STEWART GR, 1991, ANN NEUROL, V30, P758 STONE TW, 1981, EUR J PHARMACOL, V72, P411 STONE TW, 1985, NEUROSCIENCE, V15, P597 STONE TW, 1993, PHARMACOL REV, V45, P309 STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955 STOREY E, 1992, J NEUROCHEM, V58, P1975 STURCHLERPIERRAT C, 1997, P NATL ACAD SCI USA, V94, P13287 STUTZMANN JM, 1997, CNS DRUG REV, V3, P83 SUBRAMANIAM S, 1995, J PHARMACOL EXP THER, V273, P878 SUCHER NJ, 1995, J NEUROSCI, V15, P6509 SUCHER NJ, 1996, TRENDS PHARMACOL SCI, V17, P348 SUN FY, 1995, BRAIN RES, V693, P163 SUPPLISSON S, 1997, J NEUROSCI, V17, P4580 TABATABAEI A, 1992, NEUROSCI LETT, V141, P192 TAKAYAMA C, 1995, NEUROSCI LETT, V188, P89 TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53 TANAKA J, 1997, NEUROREPORT, V8, P2461 TARNAWA I, 1989, EUR J PHARMACOL, V167, P193 TAYLOR CP, 1994, NEUROLOGY, V44, P10 TAYLOR CP, 1995, ANTIEPILEPTIC DRUGS, P829 TAYLOR CP, 1995, TRENDS PHARMACOL SCI, V16, P309 TEITELBAUM JS, 1990, NEW ENGL J MED, V322, P1781 TESTA D, 1989, J NEUROL, V236, P445 THOMPSON CB, 1995, SCIENCE, V267, P1456 THOMSON AM, 1985, NATURE, V313, P479 THOMSON AM, 1989, NATURE, V338, P422 TIPTON KF, 1993, J NEUROCHEM, V61, P1191 TOGGAS SM, 1994, NATURE, V367, P188 TOGGAS SM, 1996, BRAIN RES, V706, P303 TOLLE TR, 1993, J NEUROSCI, V13, P5009 TOMS NJ, 1996, TRENDS PHARMACOL SCI, V17, P429 TOULMOND S, 1993, BRAIN RES, V620, P32 TRAYNELIS SF, 1990, NATURE, V345, P347 TRICKLEBANK MD, 1994, BRIT J PHARMACOL, V113, P729 TROTTI D, 1996, J BIOL CHEM, V271, P5976 TROTTIER Y, 1995, NATURE, V378, P403 TSAI G, 1988, J NEUROCHEM, V51, P1956 TSAI GC, 1991, BRAIN RES, V556, P151 TSUZUKI K, 1989, BRAIN RES, V481, P258 TU PH, 1996, P NATL ACAD SCI USA, V93, P3155 TURSKI L, 1991, NATURE, V349, P414 TWYMAN RE, 1995, NEURON, V14, P755 UMEMURA K, 1996, STROKE, V27, P1624 UMEMURA K, 1997, BRAIN RES, V773, P61 UMEMURA K, 1997, J CLIN PHARMACOL, V37, P719 UPTON N, 1994, TRENDS PHARMACOL SCI, V15, P456 URENJAK J, 1996, PHARMACOL REV, V48, P21 USHERWOOD PNR, 1991, PHARMACOL THERAPEUT, V52, P245 USHIJIMA H, 1995, EUR J NEUROSCI, V7, P1353 VALIVULLAH HM, 1994, J NEUROCHEM, V63, P1714 VIGNES M, 1997, NATURE, V388, P179 VILLARROYA M, 1997, EUR J PHARMACOL, V320, P249 VIZI ES, 1996, CNS DRUG REV, V2, P91 VOLLENWEIDER FX, 1990, J NEUROCHEM, V54, P1533 VOLTERRA A, 1994, J NEUROSCI 1, V14, P2924 VYKLICKY L, 1991, NEURON, V7, P971 WAFFORD KA, 1993, NEUROREPORT, V4, P1347 WAFFORD KA, 1995, MOL PHARMACOL, V47, P374 WAHLESTEDT C, 1993, NATURE, V363, P260 WALKER FO, 1989, CLIN NEUROPHARMACOL, V12, P322 WASHBURN MS, 1996, J PHARMACOL EXP THER, V278, P669 WATANABE M, 1992, NEUROREPORT, V3, P1138 WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165 WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25 WATSON BD, 1985, ANN NEUROL, V17, P497 WATSON GB, 1988, NEUROSCI RES COMMUN, V2, P169 WATSON GB, 1990, BRAIN RES, V510, P158 WEISS JH, 1988, SCIENCE, V241, P973 WEISS JH, 1989, BRAIN RES, V497, P64 WEISS JH, 1991, ADV NEUROL, V56, P311 WELLINGTON CL, 1997, BRAIN PATHOL, V7, P979 WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501 WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332 WENTHOLD RJ, 1996, J NEUROSCI, V16, P1982 WERNER P, 1991, NATURE, V351, P742 WESTBROOK GL, 1986, J NEUROSCI, V6, P3385 WHITE JK, 1997, NAT GENET, V17, P404 WHITING MG, 1963, ECON BOT, V17, P271 WIARD RP, 1995, STROKE, V26, P466 WIEDAUPAZOS M, 1996, SCIENCE, V271, P515 WILDING TJ, 1995, MOL PHARMACOL, V47, P582 WILDING TJ, 1997, J NEUROSCI, V17, P2713 WILLIAMS DB, 1991, MAYO CLIN PROC, V66, P54 WILLIAMS K, 1993, MOL PHARMACOL, V44, P851 WILLIAMS TL, 1997, ANN NEUROL, V42, P200 WILLIAMSON LC, 1988, BRAIN RES, V456, P375 WILLIS CL, 1993, BRAIN RES, V627, P55 WISDEN W, 1993, CURR OPIN NEUROBIOL, V3, P291 WISDEN W, 1993, J NEUROSCI, V13, P3582 WOKKE J, 1996, LANCET, V348, P795 WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104 WONG LA, 1993, MOL PHARMACOL, V44, P504 WONG LA, 1994, J NEUROSCI, V14, P3881 WONG PC, 1995, NEURON, V14, P1105 WOODWARD RM, 1995, MOL PHARMACOL, V47, P568 WOZNIAK DF, 1990, PSYCHOPHARMACOLOGY, V101, P47 WRATHALL JR, 1992, BRAIN RES, V586, P140 WROBLEWSKA B, 1997, J NEUROCHEM, V69, P174 WU P, 1996, NEUROREPORT, V7, P1045 XUE D, 1994, J CEREB BLOOD FLOW M, V14, P251 YAMADA KA, 1993, J NEUROSCI, V13, P3904 YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886 YANKNER BA, 1990, SCIENCE, V250, P279 YAO H, 1993, STROKE, V24, P864 YUM SW, 1990, ARCH NEUROL-CHICAGO, V47, P277 ZACZEK R, 1983, P NATL ACAD SCI USA, V80, P1116 ZEEVALK GD, 1990, J PHARMACOL EXP THER, V253, P1285 ZEEVALK GD, 1991, J PHARMACOL EXP THER, V257, P870 ZEEVALK GD, 1995, J NEUROCHEM, V64, P1064 ZEILHOFER HU, 1993, NEURON, V10, P879 ZEITLIN S, 1995, NAT GENET, V11, P155 ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213 ZHOU LM, 1997, J PHARMACOL EXP THER, V280, P422 ZOLLINGER M, 1994, J NEUROCHEM, V63, P1133 ZORUMSKI CF, 1993, NEURON, V10, P61 ZUDDAS A, 1992, J NEUROCHEM, V59, P733 ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306 ZUO J, 1997, NATURE, V388, P769 |